Megalin is an endocytic receptor highly expressed in the proximal tubules of the kidney. Recently, we demonstrated that this receptor is essential for the renal uptake and conversion of 25-OH vitamin D 3 to 1,25-(OH) 2 vitamin D 3 , a central step in vitamin D and bone metabolism. Unfortunately, the perinatal lethality of the conventional megalin knockout mouse model precluded the detailed analysis of the significance of megalin for calcium homeostasis and bone turnover in vivo. Here, we have generated a new mouse model with conditional inactivation of the megalin gene in the kidney by using Cre recombinase. Animals with a renal-specific receptor gene defect were viable and fertile. However, lack of receptor expression in the kidney results in plasma vitamin D deficiency, in hypocalcemia and in severe bone disease, characterized by a decrease in bone mineral content, an increase in osteoid surfaces, and a lack of mineralizing activity. These features are consistent with osteomalacia (softening of the bones) as a consequence of hypovitaminosis D and demonstrate the crucial importance of the megalin pathway for systemic calcium homeostasis and bone metabolism.
carriers and associated vitamins, indicating an essential function of the receptor in renal vitamin homeostasis (7) . Particular interest has been focused on a role of megalin in tubular uptake and activation of 25-OH vitamin D 3 , a central step in vitamin D metabolism. is the main vitamin D metabolite bound to DBP in the circulation (8) . This inactive precursor is taken up into PTC and converted into 1,25-(OH) 2 vitamin D 3, the active metabolite and a potent regulator of systemic calcium and bone metabolism (9, 10) . Several pathways have been implicated in the delivery of to the proximal tubules, one of which involves megalin. Because the receptor internalizes 25-OH vitamin D 3 /DBP complexes into PTC, it has been suggested that delivery requires glomerular filtration of 25-OH vitamin D 3 /DBP complexes followed by megalinmediated retrieval from the primary urine (5) . In this model, megalin activity in the proximal tubule fulfills two main functions. It prevents urinary loss of filtered 25-OH vitamin D 3 /DBP complexes, and it provides cells with the precursor required for production of 1,25-(OH) 2 
vitamin D (11).
In vivo evidence for a role of megalin in renal vitamin D homeostasis was obtained in rats and DBP-deficient mice. In perfused kidneys of the rat, inactivation of the receptor by an antagonist blocked renal uptake and conversion of 25-OH vitamin D 3 (5) . Lack of DBP expression in a knockout mouse model resulted in an inability to properly target 25-OH vitamin D 3 to the kidney and in enhanced urinary excretion of the vitamin (12) . Conceivably, megalin-deficient mice represent an important animal model to unambiguously test the contribution of this receptor to renal and systemic vitamin D metabolism. Unfortunately, the poor viability of the megalin knockout mouse model so far has precluded an in-depth investigation into that matter. Most megalin −/− mice die perinataly from a developmental defect of the forebrain and only 1-2% of the receptor-deficient animals grow up to adulthood, restricting the number of mice available for such studies (5, 13) .
Here, we have used conditional gene targeting to generate a mouse model with a kidney-specific megalin gene defect in order to circumvent the problem of perinatal lethality associated with the full megalin knockout. Mice carrying a kidney-specific megalin gene defect developed normally. However, the loss of renal megalin activity resulted in plasma vitamin D deficiency and, as a consequence, in hypocalcemia and severe osteopathy, confirming the crucial role of this receptor pathway in systemic vitamin D and bone metabolism. A targeting vector was generated to introduce lox P recombination sites into the megalin gene locus. The structure of the vector is depicted in Figure 1A . In brief, a 1-kb XbaI/EcoRI, a 3.2-kb EcoRI/HindIII, and a 4-kb HindIII fragment of the murine megalin gene were inserted into vector pFlox that contains the neomycin phosphotransferase gene driven by the phosphoglycerate kinase promoter and three lox P sites (kindly provided by J. Herz, University of Texas Southwestern Medical Center). Electroporation of the vector into murine embryonic stem (ES) cells and derivation of germ line chimeras were performed according to standard procedures. Mice homozygous for the lox P-modified megalin gene (megalin lox/lox ) were viable and fertile. For generation of line apoE Cre , the Cre recombinase (Cre) gene (provided by C. Birchmeier, Max-Delbrueck-Center for Molecular Medicine) was inserted into vector pLIV.8 (J. Taylor, University of California, San Francisco) that harbors a 3-kb fragment of the human apoE gene promoter region and a 0.2-kb fragment of the 3' gene flanking region, including the polyadenylation signal. Several transgenic mouse lines carrying the apoE-Cre transgene were produced by zygote injection. Line apoE-CreVI was used in this study. The generation of megalin −/− mice has been published before (13) . Line ROSA 26 was obtained from The Jackson Laboratory (Bar Harbor, ME). Animals used in this study were bred in-house and fed ad libitum a normal mouse diet (1% calcium, 0.7% phosphor, 1.000 IU vitamin D 3 ; V1126 Extrudat diet, Ssniff, Soest, Germany) or a vitamin D-depleted chow (0.65% calcium, 0.5% phosphor; EF R/M diet; Ssniff).
MATERIALS AND METHODS

Generation of mouse lines megalin
Endocrine parameters
Vitamin D metabolites in urine and plasma were measured by competitive protein binding assays (Immundiagnostik, Bensheim, Germany). Electrolytes were determined on a standard clinical analyzer. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of renal RNA samples was performed using Taq-man technology (Applied Biosystems, Weiterstadt, Germany) as published previously (14) .
DBP and 25-OH vitamin D 3 turnover experiments
Human DBP was purified from serum samples by immunoaffinity chromatography (15) and radiolabeled with 125 I by using the IODO-GEN method (16 3 /DBP per animal via the tail vein, followed by i.p. injection of 2 ml of 0.9% saline to increase urine output. The animals were placed in metabolic cages for urine collection. At designated time points, blood was collected by retro-orbital bleeding. The total amount of 3 H-25-(OH) vitamin D 3 excreted into the urine was determined. For quantification of nondegraded 125 I-DBP in plasma and urine, we recovered the intact protein by trichloroacetic acid precipitation before measurement.
Histology and bone histomorphometry
Standard immunohistology and electron microscopy were performed as previously described (17) . For analysis of bones, sex-and age-matched mice fed a normal or a vitamin D-deficient diet for 6 wk were injected i.p. with tetracycline (Sigma, St. Louis, MO) at a dose of 20 µg/g body weight and were killed 24 h later. Lumbar vertebrates, femur, and tibia were removed and stored in 70% ethanol. Undecalcified 7-µm sections were produced from lumbar vertebrates and prepared for histomorphometric studies of morphology (Goldner trichrome stain) or dynamic fluorescence studies of bone mineralization (unstained). Using point-counting (Zeiss integration filter II) and simple measurements (stage micrometer) the following parameters were estimated: osteoid surfaces (total trabecular bone surface covered by osteoids); osteoid volume (trabecular bone volume consisting of osteoids); osteoid width (mean width of osteoid scans estimated by two point discrimination of 20 randomly selected surfaces); resorption surface (RS, total trabecular surface occupied by scalloped resorption surface with or without osteoclasts); inactive surface (IS, trabecular bone surface without resorption and bone formation was calculated as IS = 100 -RS -formative surface); and mineralizing surface (total trabecular surface showing tetracycline fluorescence). Femur and tibia were placed in a dual energy X-ray absorptiometry (DXA) scanner for measurement of total bone mineral content. For statistical analysis, we tested the data for normal distribution and homogeneity of variances, and, where applicable, either parametric analyses or nonparametric analyses were used. Differences between groups were tested by one-way ANOVA or Kruskal-Wallis test. In case of differences, the Fisher's LSD test or the Mann-Whitney U-test was applied. P<0.05 (two-tailed) was considered statistically significant.
RESULTS
We used Cre technology as described by Rajewski et al. (18) to establish a mouse model with a kidney-specific megalin gene defect. To target the murine megalin gene, we generated the vector depicted in Figure 1A . In this vector, an EcoRI/HindIII fragment of the megalin gene locus, including the exon that encodes the membrane anchor, was flanked by the NEO selection cassette and two lox P sites on the 5' and a third lox P site on the 3' site. Additional megalin gene regions upstream and downstream of the EcoRI/HindIII fragment served as short and long homology region of recombination. Using standard ES cell technology, we generated mice carrying the targeted megalin gene through their germ line. The findings reported in this study were obtained in animals derived from two independently targeted ES cell clones that gave identical results. Mice homozygous for the modified megalin gene (megalin lox/lox ) were generated by breeding of animals heterozygous for the floxed gene locus (Fig. 1B) . Megalin lox/lox animals exhibited normal forebrain development and unimpaired viability.
In parallel, we established a mouse model with expression of Cre in the proximal tubules of the kidney. Several kidney-specific promoters driving the Cre gene were tested in transgenic mice, including promoters of the kidney androgen-regulated protein and the γ-glutamyl transpeptidase II genes, none of which resulted in significant Cre activity in PTC (data not shown). We generated a mouse line with substantial expression of Cre in the kidney by using a fragment of the human apolipoprotein (apo) E promoter to drive the Cre transgene (line apoE-CreVI; Fig.  2A ). This truncated apoE promoter element was shown previously to direct gene expression to the renal cortex in transgenic mouse models (J. Taylor, personal communication). To confirm renal Cre activity in the apoE-CreVI line (apoE Cre ), we crossed the animals with the ROSA 26 tester strain that carries a Cre-inducible lacZ gene. In mice doubly transgenic for apoE
Cre and lacZ, β-galactosidase activity was detected in the renal cortex, both in cells of the proximal and the distal tubuli (Fig. 2B ). Because megalin expression in the kidney is restricted to PTC, expression of Cre in other renal cell types was irrelevant for this study. Thus, line apoE-CreVI was considered appropriate to generate a kidney-specific megalin gene knockout.
We produced mice doubly transgenic for the floxed megalin gene and the apoE-Cre transgene (megalin lox/lox ; apoE Cre ) by breeding the individual lines. Cre-mediated recombination of the megalin gene was expected to delete the membrane anchor-encoding exon, rendering the receptor inactive. This strategy was confirmed when the expression of the protein was tested in (megalin lox/lox ; apoE Cre ) mice. As shown by Western blot analysis, the amount of megalin in renal membrane preparations from (megalin lox/lox ; apoE Cre ) animals was reduced by >90% as compared with megalin lox/lox controls ( Fig. 3) . No significant decrease in megalin levels was observed in the brain ( Fig. 3 ) or in other tissues normally expressing the receptor, including lung, intestine, ovaries, and epididymis (data not shown). Also, no soluble megalin fragment that may arise from expression of a truncated receptor was detected in tissues or urine samples (data not shown).
In addition, we confirmed the loss of renal megalin expression by immunohistology. As seen in Figure 4B , most PTC of (megalin lox/lox ; apoE Cre ) kidneys were devoid of receptor protein, similar to the situation seen in megalin −/− tissue (Fig. 4C ). Only ~10% of the tubules retained normal levels of megalin expression, likely due to an insufficient amount of Cre activity in these cells. Absence of megalin expression resulted in a loss of endocytic activity as judged by the absence of recycling membrane vesicles (dense apical tubules) ( Fig. 4E ) and the lack of uptake of DBP (Fig. 4H) . Again, few tubules stained positive for internalized DBP, reflecting a small number of megalin-expressing cells in (megalin lox/lox ; apoE Cre ) kidneys. Thus, kidneys with Cre-mediated megalin gene inactivation were indistinguishable from kidneys of megalin −/− mice (Fig. 4C, 4F , and 4I).
Consistent with a loss of megalin expression in most tubules, kidneys from (megalin lox/lox ; apoE Cre ) mice were unable to retrieve plasma proteins from the glomerular filtrate and excreted increased amounts of low molecular weight proteins into the urine (low molecular weight proteinuria) (Fig. 5A, lanes 4 and 5) . Excreted proteins included known ligands for the receptor such as DBP (Fig. 5B, lanes 4 Approximately sixfold higher levels of the labeled vitamin were found in the urine of the receptor-deficient mice (P<0.02; Fig. 6C ). Also, the ratio of 3 H-25-OH vitamin D 3 in urine vs. plasma after 16 h was dramatically increased in receptor-deficient mice (32.3 ± 7.4) as compared with control mice (9.4 ± 3.0). In conclusion, these findings demonstrated that megalin does not affect the plasma turnover of DBP that is produced and secreted by the liver normally. Rather, the receptor is essential to retrieve the fraction of 25-OH vitamin D 3 /DBP complexes that have been filtered through the glomerulus. (9) . Using quantitative RT-PCR, we tested the renal mRNA levels of 1α-HYD and 24-HYD (Fig. 7) . On a normal diet, 1α-HYD mRNA levels were increased and 24-HYD levels were reduced twofold in (megalin lox/lox ; apoE Cre ) as compared with megalin lox/lox mice, although these changes did not quite reach statistical significance. However, on a vitamin D-depleted diet, transcript levels were increased or decreased 10-fold, respectively. Levels of significance were P=0.001 (1α-HYD) and P=0.04 (24-HYD).
Finally, we analyzed the consequences of renal megalin deficiency on the bone metabolism in detail. Already, some alterations in the histological appearance of vertebral bodies were detected when megalin lox/lox and (megalin lox/lox ; apoE Cre ) mice on a normal diet were compared (Fig. 8A,  8C , and 8E). In (megalin lox/lox ; apoE Cre ) mice, the bones were characterized by an increase in resorptive cavities and osteoid-covered surfaces, indicating a state of high bone turnover. More impressively, on a vitamin D-deficient chow, vertebrates from (megalin lox/lox ; apoE Cre ) mice revealed a highly irregular and unmineralized bone surface that was largely covered by osteoid ( Fig. 8D and 8F ). No such changes were seen in megalin lox/lox animals in response to vitamin D depletion (Fig. 8B) . To test for bone mineralizing activity, we administered tetracycline i.p. and analyzed its uptake into vertebral bodies by fluorescence microscopy. Whereas in megalin lox/lox mice on a vitamin D-deficient diet, tetracycline was efficiently incorporated into the bones as shown by distinct labeling of the bone surface (Fig. 9A) , (megalin lox/lox ; apoE Cre ) animals completely lacked mineralizing activity. Rather, tetracycline was seen as a weak and blurred signal in osteoid surfaces (Fig. 9B) . Using point-counting and simple measurement, we quantified static and dynamic bone parameters in our mouse models. Megalin lox/lox and (megalin lox/lox ; apoE Cre ) mice on normal or on a vitamin D-depleted diet were analyzed (Table 2) . No significant differences in bone parameters between megalin lox/lox and (megalin lox/lox ; apoE Cre ) on a normal diet were detected. In contrast, in (megalin lox/lox ; apoE Cre ) animals on a vitamin Ddepleted diet, the total bone mineral content in femur and tibia was drastically reduced (29.5 mg) as compared with all the other groups of mice (61.8-50.4 mg). In addition, the animals exhibited a significant increase in osteoid surface, osteoid width, and osteoid volume and a concomitant decrease in the mineralizing bone surfaces. The percentage of resorptive surface area was slightly increased; however, this trend was not statistically significant. The only change in bone metabolism observed in megalin lox/lox mice in response to vitamin D depletion was a slight decrease in total bone mineral content (P<0.01). All other parameters were unchanged as compared with animals on a normal diet.
DISCUSSION
In previous studies, megalin was shown to represent an endocytic pathway that delivers DBPbound 25-OH vitamin D 3 to PTC. Uptake of the metabolite proceeds from the lumen of the proximal tubules following glomerular filtration of the vitamin/carrier complex (5, 15) . Lack of the receptor in megalin −/− mice coincided with a reduction in plasma 25-OH vitamin D 3 levels, impaired growth, and reduced calcification of bones as shown by radiographic imaging (5). Although these findings established megalin as one possible mechanism of how the kidneys take up 25-OH vitamin D 3 , the significance of this pathway for systemic vitamin D homeostasis was met with skepticism. For example, other routes (such as simple diffusion) may also contribute to renal uptake and activation of vitamin D metabolites (19, 20) . An imbalance in vitamin D and bone metabolism in megalin −/− mice may also be caused in part by the severe and complex phenotype of the surviving knockout animals (5, 13).
To address these concerns and to establish a more suitable mouse model of renal megalin deficiency, we used Cre-mediated gene targeting to inactivate the receptor specifically in the kidney of mice. Animals with a renal-specific megalin gene defect exhibited normal development and viability. Yet, loss of renal receptor activity resulted in severe tubular resorption deficiency and low molecular weight proteinuria, a phenotype shared with the megalin −/− line (7). Using (megalin lox/lox ; apoE Cre ) mice, we were able to show that megalin plays an essential role not only in tubular retrieval of vitamin D metabolites (Fig. 6 ) but also in systemic calcium and bone metabolism ( Fig. 8 and 9 ; Table 2 ).
The percent of 125 I-DBP or 3 H-25-OH vitamin D 3 excreted in the knockout as compared with the control animals was increased five-to sixfold (Fig. 6) . The total amount of tracer that was recovered likely underestimates the fraction of 25-OH vitamin D 3 /DBP complexes that is subject to glomerular filtration and reabsorption via megalin. Due to the small urine volume excreted by mice, a significant portion of the material cannot be recovered because it evaporates in the metabolic cages used for sample collection. (Table 1) . By using histomorphometry, we determined that their bone structure showed moderate but consistent morphological alterations such as irregular surfaces, indicating increased resorption and remodeling activity. This phenotype was distinctly milder than the defects observed in the megalin −/− animals on a normal diet (5), likely reflecting the residual renal megalin activity in the tissue-specific knockout line. However, after 6 wk on a vitamin D-depleted chow, the animals suffered from hypocalcemia and true severe osteomalacia. Their bones were characterized by a decrease in total mineral content; a massive increase in surface, volume, and width of osteoids; and an absence of mineralizing activity (as judged by a reduction in tetracycline uptake). The modest increase in resorptive surface area may be explained by the dramatic extent of osteoid surfaces (67%) blocking access of osteoclasts to the bones.
Taken together, our findings suggest that with a continuous supply of vitamin D metabolites, (megalin lox/lox ; apoE Cre ) animals were able to compensate for the loss of renal megalin activity; however, on a vitamin D-depleted diet, they manifested severe vitamin D deficiency and osteopathy. Remarkably, an identical phenotype to the one observed in (megalin lox/lox ; apoE Cre ) animals was seen in mice lacking DBP. In DBP −/− animals on a vitamin D-repleted diet, systemic levels of vitamin D metabolites were significantly reduced as compared with controls. Nevertheless, the animals did not exhibit obvious signs of major bone formation defects. In contrast, after 4 wk on a vitamin D-depleted chow, they suffered from severe osteomalacia, characterized by an increase in osteoid parameters and a defect in bone mineralization (12) . animals likely originate from extra-renal sources. These sources may contribute up to 30% of circulating vitamin D metabolites (Table 1) . Accordingly, the levels of 1,25-(OH) 2 vitamin D 3 metabolites in (megalin lox/lox ; apoE Cre ) mice probably reflect production of the metabolite both in extra-renal tissues as well as in some PTC that retained normal megalin expression (Fig. 4) . Although megalin-and DBP-independent mechanisms (as in DPB −/− and megalin −/− mice) produce significant amounts of vitamin D metabolites, these sources are not able to sustain normal bone metabolism under stress conditions such as a vitamin D-depleted diet. This observation indicates that production of 1,25-(OH) 2 vitamin D 3 in extra-renal cell types may serve local rather than systemic functions and that these pathways are unable to adapt to changes in vitamin D metabolism. Consistent with this hypothesis, we were unable to detect any increase in 1α-HYD mRNA levels in extra-renal tissues of (megalin lox/lox ; apoE Cre ) mice in response to vitamin D deprivation (data not shown), as was readily demonstrated for the renal enzyme (Fig.  7) .
Apart from a role in renal uptake and activation of vitamin D metabolites, many other functions have been attributed to megalin in PTC. Similar to the tubular clearance of vitamin D metabolites, the receptor was also shown to reabsorb vitamins A and B 12 in complex with their respective carriers, indicating an equally important role in vitamin A and B 12 homeostasis (4, 6) . Further proposed functions for megalin include renal uptake of nephrotoxic compounds (23, 24) , regulation of sodium and calcium reabsorbtion (25, 26) , and cellular signal transduction (27) (28) (29) (30) . Mice with a kidney-specific megalin gene defect established in this study will enable us to rigorously test the contribution of the receptor to the many suggested functions and to uncover new ones previously not considered. ) animals on vitamin D-depleted diet and all the other groups were determined as described in the Materials and Methods section. n, number of animals. 2) and two (megalin lox/lox ; apoE Cre ) mice (lanes 3 and 4) were subjected to Western blot analysis by using an anti-megalin antiserum and enhanced chemoluminescence. The protein band corresponding to megalin is indicated by arrowheads. Undecalcified Goldner stained sections were produced from the lumbar vertebrates of megalin lox/lox animals (A and B) and (megalin lox/lox ; apoE Cre ) animals (C and D) on a normal or a vitamin D-depleted diet. E and F represent higher magnifications of sections from (megalin lox/lox ; apoE Cre ) mice on a normal (E) or a vitamin D-depleted chow (F). Green staining represents calcified bone. Uncalcified matrix (osteoid surfaces) on vertebral bodies of (megalin lox/lox ; apoE Cre ) mice are stained in red and indicated by arrows in F. Resorptive cavities are highlighted by arrowheads (magnification: A-D, ×100; E and F, ×200). 
